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Abstract T-cadherin is a unique member of the cadherin
superfamily of adhesion molecules. In contrast to ‘‘classi-
cal’’ cadherins, T-cadherin lacks transmembrane and
cytoplasmic domains and is anchored to the cell membrane
via a glycosilphosphoinositol moiety. T-cadherin is pre-
dominantly expressed in cardiovascular system. Clinical
and biochemical studies evidence that expression of
T-cadherin increases in post-angioplasty restenosis and
atherosclerotic lesions—conditions associated with endo-
thelial dysfunction and pathological expression of adhesion
molecules. Here, we provide data suggesting a new sig-
naling mechanism by which T-cadherin regulates endo-
thelial permeability. T-cadherin overexpression leads to
VE-cadherin phosphorylation on Y731 (b-catenin-binding
site), VE-cadherin clathrin-dependent endocytosis and its
degradation in lysosomes. Moreover, T-cadherin overex-
pression results in activation of Rho GTPases signaling and
actin stress fiber formation. Thus, T-cadherin up-regulation
is involved in degradation of a key endothelial adhesion
molecule, VE-cadherin, resulting in the disruption of
endothelial barrier function. Our results point to the role of
T-cadherin in regulation of endothelial permeability and its
possible engagement in endothelial dysfunction.
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Introduction
Endothelium is a key regulator of vascular homeostasis,
since it performs a barrier function and responds to phys-
ical and chemical signals by producing a broad spectrum of
factors that regulate vascular tone, cellular adhesion,
smooth muscle cell migration and proliferation, vessel wall
inflammation, and thrombogenicity [1]. Endothelial dys-
function manifests itself in various pathological conditions
such as atherosclerosis, hypertension, and diabetes melli-
tus. More specifically, at the physiological level endothelial
dysfunction is characterized by changes in endothelial
phenotype and particularly by the expression pattern of
adhesion molecules involved in the cell–cell adhesion and
endothelial permeability [2]. VE-cadherin plays a crucial
role in maintaining endothelial cell monolayer integrity and
regulation of its activity/localization at the adherens junc-
tions is under control of permeability regulating factors [3].
VE-cadherin mediates cell adhesion via homophilic
Ca2?-dependent interaction between its extracellular
domains on the neighboring cells. Similar to other ‘‘clas-
sical’’ cadherins, VE-cadherin interacts via its cytoplasmic
tail with p120ctn, b-catenin, a-catenin, plakoglobin, and
cytoskeleton; thus, mediating strong cell–cell adhesion [3–
5]. Most of the conditions that increase endothelial per-
meability affect the organization of the cadherin–catenin
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complex leading to the cell retraction and/or formation of
intracellular gaps [5]. Several publications indicate that
there is a correlation between changes in the stability of
VE-cadherin-mediated junctions and phosphorylation sta-
tus of proteins of cadherin–catenin complex [3, 5].
As it has been found recently by us and others, another
cadherin namely T-cadherin (T-cad) expressed in endo-
thelial cells, can modulate endothelial permeability [6, 7];
however, the exact mechanisms of T-cad participation
remain obscure. T-cad is a unique member of the cadherin
superfamily of adhesion molecules mediating Ca2?-
dependent cell–cell adhesion [8]. Unlike other cadherins,
T-cad does not have either transmembrane or cytoplasmic
parts and is anchored to the cell membrane via a glyco-
silphosphoinositol (GPI) moiety [9]. The lack of an intra-
cellular domain in T-cad structure suggests that T-cad is
involved in the intracellular signaling rather than in stable
cell–cell adhesion. Indeed, it was demonstrated that plating
of endothelial cell on the substratum containing recombi-
nant T-cad results in the rearrangement of actin cytoskel-
eton and cell detachment mediated via activation of RhoA
and Rac1 signaling [7, 10]. In the present study, we used
endothelial cells and examined the responses of RhoA,
Rac1, and Cdc42 and their downstream signaling adaptors,
ROCK-II and PAK1, as well as the changes in organization
of actin cytoskeleton to overexpression of T-cad or to
suppression of its native expression.
In our laboratory, it was shown that T-cad is predomi-
nantly expressed in a cardiovascular system in endothelial
cells, smooth muscle cells, pericytes and cardiomyocytes
[11, 12]. Expression of T-cad increases in the cases of post-
angioplasty restenosis and atherosclerotic lesions—condi-
tions associated with the increased cell migration, endo-
thelial dysfunction, and pathological expression of
adhesion molecules [11, 12]. Moreover, it has been
reported that T-cad plays an essential role in revasculari-
zation after experimental limb ischemia [13].
The above-mentioned data prompted us to ask a question
if T-cad is involved in regulation of the endothelial barrier
function and to explore the possible mechanisms for its
participation. To perform this study, we developed lentiviral
constructs for overexpression or suppression of T-cad in
primary endothelial cells. It was found that the overexpres-
sion of T-cad caused the increase in permeability of endo-
thelial monolayer to macromolecules, contrary to which the
suppression of native T-cadherin (si-T-cad) resulted in
reduced permeability. We assessed the localization of VE-
cadherin and revealed the phosphorylation status of specific
tyrosine residues of VE-cadherin in control, T-cad and si-T-
cad cells. It was shown that T-cad overexpression induced
VE-cadherin phosphorylation on Y731, but not on Y658,
resulting in VE-cadherin clathrin-mediated endocytosis and
degradation in lysosomes. Thus, we suggest the existence of
a new biochemical pathway by which T-cad regulates
endothelial permeability. We suppose that the upregulation
of T-cad expression is an important factor under conditions
characterized by vascular leakage.
Materials and methods
Cell culture and reagents
Human umbilical vein endothelial cells (HUVEC) of the
2nd passage (HUVEC, CC-2517, Lonza) were grown in
EBM-2 media, supplemented with SingleQuots Kit (CC-
4176, Lonza). Cells were maintained at 37 C in a
humidified atmosphere of 5 % CO2 and 95 % air. Cells
were used at passages 0–4.
Lentiviral constructs
The lentiviral T-cad expressing construct pSIH-H1-Tcad
was prepared using a pSIH1-H1-puro lentiviral vector
(System Bioscience), as described in supplementary
materials. For RNA interference mediated T-cad gene
silencing the lentiviral construct pSIH-H1-puro-siTcad was
used, as described in supplementary materials. For control
transduction we used the constructs described before [7].
HUVEC of the 2nd passage were transduced with pseud-
oviral particles for overexpression of T-cad or silencing (si-
T-cad) or for control experiments (control). The T-cad
expression was assessed by immunofluorescent staining
and immunoblotting with antibodies against human T-cad
78 h after transduction. The data was normalized by the
GAPDH content.
Antibodies and reagents
The following antibodies were used: rabbit anti-T-cad (ProSci
Inc.); mouse anti-VE-cadherin, rabbit anti-phospho VE-cad-
herin (Y658), and rabbit anti-phospho VE-cadherin (Y731)
(Abcam); mouse anti-N-cadherin (Santa Cruz); mouse anti-b-
catenin and mouse anti-phospho-b-catenin (T41) (Abcam);
mouse anti-p120ctn (Santa Cruz); rabbit anti-clathrin (Abcam);
rabbit anti- PAK1 and rabbit anti-phospho-PAK1 (T212)
(Abcam); rabbit anti-ROCK-II (Santa Cruz); rabbit anti-Src
and rabbit anti-phospho-Src (Y418) (Abcam); mouse anti-p38
(Sigma) and rabbit anti-phospho-p38 (T180?Y182) (Abcam);
rabbit anti-Erk1?Erk2 ant rabbit anti-phospho-Erk1?Erk2
(T185?T202) (Abcam); mouse anti-ZO-1 (Invitrogen);
mouse anti-occludin (Abcam); mouse anti-claudin-5 (Invit-
rogen); mouse anti caveolin-1 (BD); rabbit anti-EEA1 (Ab-
cam); rabbit anti-LAMP1 (Abcam); LysotrackerRed
(Invitrogen); phalloidin AlexaFluor488 (Molecular Probes);
secondary anti-mouse and anti-rabbit AlexaFluor488 or
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AlexaFluor594 antibodies (Molecular Probes) were used in
immunofluorescence techniques. Rabbit anti-GAPDH (Santa
Cruz) antibody was used in Western blotting for protein
loading control; the secondary antibodies in Western blotting
were HRP-conjugated donkey anti-mouse or donkey anti-
rabbit IgG (Jackson Immuno-Research Laboratories). Chem-
icals for Western blotting were from Bio-Rad, buffers for
immunofluorescence were purchased from GIBCO. Trypsin
and gelatin were purchased from Sigma.
Western blotting
HUVEC grown to confluency were washed twice with ice-
cold HBSS and lysed in 29 Laemmli’s sample buffer
containing b-mercaptoethanol and Protease Inhibitor
Cocktail (Sigma). After 10 min of incubation lysates were
disrupted using a G21 syringe and heated for 10 min at
90 C, electrophoresed on SDS-PAGE (7.5 or 14 %) gel
and electroblotted onto nitrocellulose membranes (Immo-
bilon, Millipore). Kaleidoscope Prestained Standards (Bio-
Rad) were used as molecular weight markers. Membranes
were pre-blocked for 30 min in blocking buffer, containing
5 % (w/v) of nonfat milk, 0.5 % Tween 20 in PBS and then
incubated with primary and secondary antibodies for 1 h.
The signal was developed using ECLTM Western Blotting
Detection Reagents and a CL-XposureTM Film (all from
Amersham). All experiments were repeated at least three
different times in triplicates. Densitometric analysis of
blots was performed using GS-800 Calibrated Densitome-
ter (Bio-Rad) and Quantity One 4.6 Software (Bio-Rad).
Immunofluorescence and confocal imaging
HUVEC f the 2nd passage were placed on gelatin-coated
glass coverslips in concentration 2 9 104 cells/cm2 and
grown to confluence. For intracellular marker staining cells
were washed with warm HBSS, fixed with 4 % parafor-
maldehyde, permeabilized for 5 min with 0.2 % Triton
X-100 (if unless otherwise indicated), and blocked with
10 % normal donkey serum with 1 % BSA. After sequential
incubation with primary and secondary antibodies according
to concentrations recommended by manufacturer, coverslips
were mounted with ProLong Antifade reagent with DAPI
(Invitrogen) for nuclei staining. In internalization assay
HUVEC were preincubated with dynasore hydrate (Sigma)
in final concentration 80 lM for 2 h, or LysoTrackerRed
(Invitrogen, Ex/Em: 577/590 nm) for 60 and 120 min, or
Y27632 in final concentration 10 lM (Sigma) for 12 h
before immunofluorescent staining.
Images were acquired by confocal laser scanning
microscopy using a microscope system (TCS SP5, Leica)
equipped with a Plan-Apo 960, 1.40 NA oil objective and
488- and 543- Argon lasers lines. Imaging was performed
at room temperature using Leica Type F immersion oil.
DAPI, AlexaFluor488 and AlexaFluor594 fluorescence
was sequentially excited using lasers with wavelengths of
405 (DAPI), 488 (AlexaFluor488), and 594 (AlexaFlu-
or594). All images were captured using the same confocal
gain and offset settings. Images (1024 9 1024 or
2048 9 2048 pixels) were saved as TIFF files in Leica
LAS software and then complied in Photoshop (version
CS5, Adobe) to generate figures. Labeling detected in
individual channels is presented in red and green and then
merged in individual panels; overlap of red and green
staining is revealed in yellow. Results of at least three
independent experiments are presented. Co-localization
was acquired by immunofluorescence confocal analysis
and quantitated using the ImageJ co-localization plug-in.
Isolation of active Rho GTPases (GST pull-down assay)
Active Rho GTPases (RhoA, Rac1, and Cdc42) were iso-
lated using commercial RhoA/Rac1/Cdc42 activation
Assay Combo kit (Cellbiolabs Inc.). Active RhoA, Rac1,
and Cdc42 GTPases were determined by electrophoresis in
14 % polyacrylamide gel with subsequent immunoblotting
in the presence of monoclonal antibodies specific for each
GTPase. For the positive control commercial available
lysates were used. The total level of GTPases was deter-
mined in the lysates prepared as described. Results of three
independent experiments are presented.
In vitro determination of endothelial monolayer
permeability
The endothelial cells monolayer permeability was assessed
as described earlier [7]. In brief, HUVEC of the 3rd pas-
sage were plated (1 9 105 cells/well) into the upper
chamber of the double-chamber tissue culture plates (pore
size 0.4 lm, Transwell; Corning, USA) and grown to
confluency. 72 h later, the upper chamber of the Trans-
well was supplemented with a solution of FITC-conju-
gated dextran (FITC-dextran, Mr 40,000 Da, Sigma), at the
final concentration of 10 lg/ml. After 60 min, a 20 ll
aliquot was taken from the lower chamber, and intensity of
the FITC fluorescence was measured using the Envision
Multilabel Reader (Perkin Elmer) at 525 nm wavelength.
Samples for all subsequent measurements were taken every
60 min. The experiment was performed in 4 parallels and
repeated 6 times.
Trypsinization experiments
To distinguish between intracellular and cell surface pools
of VE-cadherin, HUVEC were rinsed in HBSS and
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incubated in 0.25 % trypsin/EDTA (GIBCO) at 37 C to
proteolytically remove cell surface VE-cadherin [14].
Trypsin was subsequently inactivated using EGM-2 media
with serum, and cells were centrifuged at 2,000 rpm/4 C.
Cell pellets were dissolved in 29 Laemmli’s sample buffer
for Western blotting analysis as described above. For
controls, parallel cultures were harvested in 29 Laemmli’s
sample buffer without trypsinization.
Subcellular fractionation
Cellular fractions (membrane, cytosolic, and nuclear) were
obtained using the QproteomeTM Cell Compartment kit
according to manufacturer’s instructions. Cellular fractions
were obtained with specific extraction buffer according to
the manufacturer’s instructions (Qiagen). Protein concen-
tration in each fraction was determined using the BCA
protein assay kit (Pierce Biotechnology, Rockford, IL).
Equal amounts of protein (20 lg) were subjected to 10 %
SDS-PAGE and transferred to a polyvinylidene fluoride
(PVDF) membrane. Purity and consistency of fractions was
confirmed using antibodies against markers for different
subcellular compartments: anti-EEA1 (to detect membrane
and early endosomal proteins) and anti-LAMP1 (lysosomal
marker to detect cytosolic proteins) (data presented in
supplementary materials, Supplemental Fig. S1).
Statistical processing of results
Statistical analysis was performed using Statistica 6.0
software. Values are expressed as mean ± standard error
of mean (SEM) for normally distributed data and median
and percentiles (25–75 %) for not normal data or small
samples. If normality of data was confirmed (according to
Kolmogorov–Smirnov test and Shapiro–Wilk’s W test)
comparison of independent groups was performed by
Student t test, if not or size of the analyzed sample was less
than 10 cases—by Mann–Whitney U-criteria. Multiple
comparisons were performed using one-way ANOVA for
normally distributed data, otherwise—by Kruskall–Wallis
test. Statistical significance was defined as p-value \0.05
and all reported statistical tests were two-tailed.
Results
Distribution of T-cadherin in HUVEC’s cell fractions
after lentivirus transduction
The role of T-cad in the regulation of endothelial barrier
function was studied using lentivirus constructs for si-T-
cad or enhancement of its native expression (T-cad). The
content of T-cad in total lysates of HUVEC along with the
membrane, cytosolic, and nuclear fractions was assessed
after cell fractionation using QproteomeTM Cell Compart-
ment kit and Western blotting (Fig. 1a, c) with densito-
metric analysis (Fig. 1b, d–f) 72 h after transduction.
Purity and consistency of fractions was confirmed using
antibodies against markers for different subcellular com-
partments: anti-EEA1 (to detect membrane and early
endosomal proteins) and anti-LAMP1 (lysosomal marker
to detect cytosolic proteins) (data presented in supple-
mentary materials, Supplemental Fig. S1).
After HUVEC transduction with control virus, T-cad
expression in the total lysates was observed in two forms:
mature (mol wt 105 kDa) and precursor (mol wt 130 kDa)
forms (Fig. 1a); in the membrane fraction T-cad was mainly
present in the mature form; however, the precursor form was
also detected; in the nuclear and cytosolic fractions both forms
of T-cad were detected (Fig. 1c). Overexpression of T-cad
resulted in a significant increase in T-cad content in total
lysates (Fig. 1a), membrane, cytosolic, and nuclear fractions
in both, the precursor and mature forms (Fig. 1c). The si-T-
cad expression revealed virtually no precursor form of T-cad
in the total lysates; however, the trace amounts of the mature
form were still present (Fig. 1a). The absence of the precursor
and the presence of the mature form of T-cad in total lysates
indicate that after mRNA suppression the synthesis of new
T-cad molecules has been practically stopped. After frac-
tionation both forms of T-cad almost disappeared from the
nuclear and cytosolic fractions, while in the membrane frac-
tion mature form could be still detected (Fig. 1c). Thus, the
overexpression of T-cad resulted in the overall increase in
production of both, mature and precursor T-cad forms in all
cell fractions, accounting for the T-cad synthesis and transport
to the plasma membrane. Upon T-cad suppression firstly the
precursor form disappeared, reflecting the suppression of
mRNA with siRNA, while the trace amounts of mature T-cad
still could be detected in the membrane fraction 72 h after
transduction. These data confirmed that the created lentiviral
constructs were effective and increased the overall expression
of T-cad in T-cad cells; the construct for T-cad gene silencing
significantly inhibited mRNA translation, while the lifetime of
the T-cad on the membrane was longer than 72 h.
T-cadherin expression regulates endothelial monolayer
permeability
To study the role of T-cad in the regulation of endo-
thelial barrier function, we investigated the influence of
T-cad on monolayer integrity using endothelial perme-
ability assay for FITC-dextran molecules. Upon trans-
duction, HUVEC were cultured for at least 72 h until the
formation of a long-term monolayer. The integrity of the
monolayer was verified using light microscopy before
each permeability experiment. FITC-dextran solution was
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added into the upper chamber of the Transwell system.
Aliquots of the media from the lower chamber were
taken and measured every 60 min (Fig. 1g). T-cad
overexpression in HUVEC significantly elevates the
monolayer permeability compared to the control so that
6 h later the difference increased by 1.42 times. In
monolayer with si-T-cad the permeability to FITC-
dextran was markedly reduced approximately by 1.47-
fold compared to the control (Fig. 1g). Conclusively,
these results suggest that T-cad expression regulates
endothelial barrier function and its permeability to mac-
romolecules: overexpression of T-cad increased endo-
thelial permeability, while suppression of T-cad
decreased it.
Fig. 1 T-cadherin expression in HUVEC after lentivirus transduc-
tion. HUVEC cells at the 2nd passage were transduced by lentiviral
construct for overexpression of T-cadherin (T-cad), T-cad silencing
(si-T-cad) or control (control). Expression of T-cad was verified by
Western blotting using anti-T-cad antibodies followed by densito-
metric analysis. a Expression T-cad in the total lysates of T-cad, si-T-
cad, and control. In control T-cad was detected in precursor
(130 kDa) and mature (105 kDa) forms. Upon overexpression, the
content of precursor and mature forms of T-cad increased in T-cad
cells compared to control; in si-T-cad, the expression of T-cad
precursor was completely suppressed with only trace amounts of
mature form detected. Western blotting of total lysates of three
independent experiments was analyzed by densitometry analysis in
(b) (n = 3; *, ** P at least \0.05). Protein loading was normalized
using anti-GAPDH antibodies. c Cell lysates from HUVEC were
fractionated and each cell fraction with equal protein loading was
analyzed for T-cad content followed by densitometry (d), (e), (f). In
control and in T-cad cells, T-cad was detected in membrane,
cytosolic, and nuclear fractions in precursor and mature forms.
However, T-cad expression was highly upregulated in T-cad cells
compared to control; in si-T-cad expression of T-cad in all cellular
fractions was significantly reduced. Western blotting was normalized
by GAPDH level. Representative blots of three independent exper-
iments are shown with densitometry analysis histograms (n = 3; *,
** P at least \0.05). g Endothelial monolayer permeability depends
upon T-cad expression. Endothelial monolayer permeability was
measured using FITC-dextran. FITC-dextran at the final concentra-
tion 10 lg/ml was applied to the upper chamber containing mono-
layers of untransfected cells (untransfected HUVEC), control, T-cad,
or si-T-cad cells. Samples from the bottom chambers were probed
every 60 min and tested at 525 nm wavelength. Data are presented as
the mean ± SEM (* P \ 0.001, n = 24). T-cad overexpression
resulted in increased monolayer permeability and 6 h later it was
1.42-fold greater than in control. On the contrary, in si-T-cad cells
permeability to FITC-dextran was markedly reduced, approximately
by 1.47-fold compared to control
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T-cadherin induces gap formation and loss of VE-
cadherin from cell–cell contacts in HUVEC
The regulation of VE-cadherin localization and integrity is
essential for the endothelial barrier function [3]. We
hypothesized that T-cad may regulate the endothelial
permeability by changing the expression/localization of
VE-cadherin in the cells. Expression of VE-cadherin in
T-cad, si-T-cad, or control cells was assessed by Western
blotting (Fig. 2a); and followed by densitometric analysis in
total lysates, cell lysates after trypsinization and cells
lysates after subcellular fractionation (Fig. 2c, d–f).
Fig. 2 T-cad overexpression results in VE-cadherin accumulation in
the cytosolic fraction of HUVEC cells and induces gap formation.
a Expression of VE-cadherin in T-cad, si-T-cad, or control cells was
analyzed by Western blotting with anti-VE-cadherin antibody and
followed by densitometric analysis in (c), (d), (e), and (f). To
distinguish between cell surface and intracellular pools of VE-
cadherin, the membrane-bound VE-cadherin was proteolytically
removed by incubation in trypsin/EDTA. Trypsinization revealed
statistically significant increase in the content of intracellular VE-
cadherin in T-cad cells compared to control, while in si-T-cad cells on
the contrary the amount of intracellular VE-cadherin was reduced.
Subcellular fractionation confirmed the reduction of VE-cadherin
content in the membrane and its increase in the cytoplasm in T-cad
cells. In si-T-cad cells VE-cadherin in the membrane fraction
increased significantly, while in the cytosolic—it was almost
undetectable. Western blotting data of VE-cadherin content in cell
lysates was evaluated and normalized by GAPDH level. Represen-
tative blots of three independent experiments are shown and
densitometry analysis histograms are given (n = 3; *, ** P at least
\0.05). b To preserve the integrity of the cell membrane proteins,
double-immunofluorescent staining of HUVEC using antibodies to
T-cad and VE-cadherin was carried out without permeabilization.
Representative examples of confocal image captures using the same
confocal gain and offset settings are presented (T-cad—green
fluorescence, VE-cadherin—red fluorescence). Nuclei appear blue
after DAPI staining. VE-cadherin staining at cell–cell contacts in
T-cad cells is much weaker than in control. Gaps at VE-cadherin cell–
cell contacts are indicated by white arrows. Bar 20 lm
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Localization of VE-cadherin was evaluated by immuno-
fluorescent staining with confocal microscopy (Fig. 2b).
Western blotting of total lysates 72 h after cell HUVEC
transduction showed statistically significant reduction in
VE-cadherin content in T-cad cells compared to cont or si-
T-cad cells (Fig. 2a, upper panel). Trypsinization experi-
ments demonstrated that in contrast to cont or si-T-cad
HUVEC, in T-cad HUVEC the main pool of VE-cadherin
was located in the cytoplasm (Fig. 2a). This was further
confirmed by subcellular fractionation and densitometric
analysis of Western blotting results. In T-cad cells there was
a small but statistically significant reduction in VE-cadherin
content in the membrane fraction and obvious increase in
the cytosolic fraction (Fig. 2d, e). In contrast, in si-T-cad
cells the content of VE-cadherin significantly increased in
the membrane fraction and decreased in the cytoplasm
according to densitometry data (Fig. 2f). These results
indicated that T-cad overexpression caused the reduction in
the amount of VE-cadherin present on the cell membrane,
while suppression of T-cad, on the contrary, resulted in the
increased VE-cadherin localization on the membrane.
To visualize VE-cadherin localization in endothelial
cells with different expression level of T-cad, we concen-
trated on VE-cadherin expression in the areas of intracel-
lular contacts. Double-immunofluorescent staining with
antibodies against T-cad and VE-cadherin was performed
without permeabilization to preserve the integrity of
cytoplasmic membranes. All images were captured using
the same confocal gain and offset settings. In T-cad cells
VE-cadherin staining at cell borders became intermittent
(arrows in Fig. 2b); in addition VE-cadherin staining at the
cell membrane was observed in the meshwork-like pattern.
T-cad suppression, on the contrary, increased the thickness
of VE-cadherin contacts, while in accordance with Western
blotting and densitometry results almost no VE-cadherin
could be detected in the cytoplasm (Fig. 2b). The disap-
pearance of VE-cadherin from cell margins and disruption
of the linear staining of VE-cadherin at intracellular junc-
tions of T-cad cells was accompanied by the emerging gaps
between the cells (arrows in Fig. 2b); while, in si-T-cad
cells no gaps were observed.
According to Western blotting data T-cad expression exer-
ted no obvious effect on N-cadherin or tight junction proteins
occludin, claudin-5, or ZO-1 (Supplemental Fig. S2a, b).
Thus, our results suggest that T-cad overexpression in
endothelial cells selectively disrupts VE-cadherin adhesive
junctions and induce the formation of gaps between
endothelial cells; this is accompanied by VE-cadherin
accumulation in the cytoplasm and increased permeability
of endothelial monolayer. Suppression of T-cad causes
quite the opposite effect. We hypothesized that T-cad-
mediated disruption of VE-cadherin adhesive contacts
could result from the increased VE-cadherin endocytosis.
T-cadherin overexpression induces VE-cadherin
internalization via clathrin-dependent pathway
and lysosomal degradation
To test the hypothesis that T-cad overexpression induces
clathrin-dependent endocytosis of VE-cadherin, we tested
the co-localization of VE-cadherin with clathrin using
double-immunofluorescent staining of HUVEC. Confocal
high-resolution images were captured with equal gain and
offset settings. As shown in Fig. 3a, in T-cad cells VE-
cadherin co-localized extensively with clathrin on the
surface of endothelial cells (clathrin-coated pits are shown
by white arrows and depicted in the lower panel of Fig. 3a)
as well as in the cytoplasm; while, in control and si-T-cad
cells co-localization of VE-cadherin with clathrin was less
pronounced. This co-localization effect appeared to be
specific for clathrin and VE-cadherin, since no co-locali-
zation of VE-cadherin with caveolin-1 could be detected in
T-cad, control, or si-T-cad cells (Supplemental Fig. S2c).
To confirm this, we applied inhibitory analysis using
dynasore at the final concentration 80 lM [15]. Experi-
ments with dynasore showed the decreased clathrin stain-
ing at the complete absence of VE-cadherin co-localization
with clathrin in the membrane fraction (Fig. 3b, lower
panel) and in the cytoplasm of T-cad, si-T-cad, and control
cells (Fig. 3b). This data confirmed our hypothesis that
overexpression of T-cad leads to VE-cadherin endocytosis
via clathrin-dependent pathway.
To determine whether the internalized VE-cadherin was
subjected to further degradation in lysosomes we carried
out co-localization experiments of VE-cadherin and 75 nM
LysotrackerRed, a fluorescent lysosome marker, as
described before [16]. Control, T-cad, and si-T-cad HU-
VEC were preincubated with LysotrackerRed for 60 min
(Fig. 4a) and 120 min (Fig. 4b), immunostained using
antibodies against VE-cadherin and analyzed using high
resolution confocal microscopy analysis. After pre-incu-
bation with lysosome marker (especially after 120 min),
co-localization of VE-cadherin with LysotrackerRed was
much more pronounced in the cytoplasm of T-cad cells
than in control and especially in si-T-cad cells (Fig. 4b),
thus pointing to enhanced internalization and degradation
of VE-cadherin in T-cad cells [14, 17].
Taken together these data indicate that T-cad overex-
pression results in the increase in clathrin-dependent
endocytosis of VE-cadherin followed by its subsequent
degradation in lysosomes.
T-cadherin regulates phosphorylation level of VE-
cadherin (Y731) in HUVEC
Intracellular domain of VE-cadherin is known to become
phosphorylated on tyrosine residues [18, 19]. We assumed
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that overexpression of T-cad can lead to tyrosine phos-
phorylation of VE-cadherin resulting in its subsequent
degradation in lysosomes. VE-cadherin domain containing
Y731 was predicted to interact with b-catenin, while
Y658—to mediate VE-cadherin binding to p120ctn [20–
22]. Therefore, the question was whether the phosphory-
lation of these two residues correlates with T-cad-depen-
dent VE-cadherin internalization.
To answer this, total lysates of cont, T-cad, and si-T-cad
HUVEC were analyzed by Western blotting using phos-
pho-specific antibodies directed against cytoplasmic
domain of VE-cadherin phosphorylated on either Y658 or
Y731. Antibodies to phospho-VE-cadherin have been
previously used to reveal the phosphorylation of VE-cad-
herin on Y658 or Y731 [23, 24]. It was found that T-cad
overexpression resulted in dramatic increase in phosphor-
ylation level of VE-cadherin on Y731 compared to control,
while phosphorylation on Y658 remained unchanged
(Fig. 5). In si-T-cad cells virtually no Y731-phosphory-
lated form of VE-cadherin was present, while Y658
phosphorylation status was unchanged. These data indicate
that T-cad overexpression resulted in enhanced phosphor-
ylation of VE-cadherin on Y731, but not on Y658.
We tested if T-cad expression impacts localization and
phosphorylation status of b -catenin and p120ctn (Fig. 6).
For that cell fractionation and Western blotting with den-
sitometric analysis was performed that revealed no statis-
tically significant difference in b-catenin content in the
nuclear and cytosolic fractions upon T-cad overexpression
compared to control (Fig. 6a, d–f), though there was a
tendency in the increase in b-catenin content in the nuclear
fraction (Fig. 6f). The amount of membrane and phos-
phorylated b-catenin was also similar between control and
T-cad cells (Fig. 6b, g). No statistically significant differ-
ence was found in the content of b-catenin in the nuclear,
cytosolic, or membrane fractions of si-T-cad and control
cells (Fig. 6a, d–f). Also, there was no statistically relevant
difference in the amount of phosphorylated b-catenin
between si-T-cad and control cells (Fig. 6b, g).
Interestingly, while the amount of p120ctn was the same
in the cytosolic, membrane, and nuclear fractions of control
and T-cad cells, the content of p120ctn in the membrane
fraction of si-T-cad was dramatically increased (Fig. 6c, h,
j, k). These suggest the possible involvement of p120ctn in
the enhanced VE-cadherin-mediated barrier function as
judged by the decreased endothelial cell permeability to
FITC-dextran in cells with downregulated T-cad. Presum-
ably, p120ctn accumulation in the membrane area of si-T-
cad cells could prevent the internalization of VE-cadherin
and stabilize the adhesive contacts. By and large these
results indicate that T-cad overexpression induces Y731
phosphorylation of VE-cadherin, which may be the
mechanism underlying the increased clathrin dependent
internalization of VE-cadherin and increased endothelial
monolayer permeability. To determine the exact role of b-
catenin and p120ctn in this process, further research is
needed.
T-cadherin activates small G proteins RhoA, Rac1,
Cdc42, and induces actin stress fibers formation
in HUVEC
Activation of Rho GTPases (RhoA, Rac1, and Cdc42) is
known to influence endothelial barrier permeability [25,
26]. In order to identify the possible involvement of Rho
GTPases in the T-cad-mediated effects on endothelial
permeability we isolated active forms of Rho GTPase by
precipitation using lysates of control, T-cad, and si-T-cad
HUVEC. It was found that T-cad overexpression in HU-
VEC resulted in the activation of RhoA, Rac1, and Cdc42;
while, the total protein content of Rac1, Cdc42, and RhoA
remained unchanged (Fig. 7a). Noteworthy, no active
forms of RhoA and Cdc42 were detected in control or si-T-
cad cells (Fig. 7a).
Rho family associated kinases, ROCK-II and PAK1 are
direct downstream targets of Rho family GTPases (ROCK-
II is activated by RhoA, while PAK1 is a target kinase of
activated Rac1 and Cdc42) [27]. T-cad overexpression
correlated nicely with an increase in the ROCK-II content
and the level of phosphorylated PAK1 comparing to con-
trol (Fig. 7b). In si-T-cad HUVEC the content of ROCK-II
and the degree of phosphorylation of PAK1 were reduced
compared to control cells (Fig. 7c).
The data on Rho GTPases, ROCK-II and PAK1 acti-
vation was further confirmed by functional rearrangement
of the cytoskeleton HUVEC. As presented in supplemen-
tary materials T-cad overexpression induced stress fiber
formation, while in si-T-cad cells actin stress fiber
Fig. 3 T-cad overexpression induces VE-cadherin internalization via
clathrin-dependent pathway in HUVEC ells. a Confocal high-
resolution images of T-cad, si-T-cad, or control HUVEC double-
immunostained with antibodies against clathrin (green fluorescence)
and VE-cadherin (red fluorescence). Nuclei appear blue after DAPI
staining. Yellow fluorescence corresponds to VE-cadherin and clathrin
co-localization (white arrows, also in the lower panel). b To inhibit
clathrin-dependent endocytosis, control, T-cad, and si-T-cad cells
were treated with 80 lM dynasore for 2 h prior to staining. Cells were
double-stained with anti-clathrin (green fluorescence) and anti-VE-
cadherin (red fluorescence) antibodies. Nuclei were counterstained
with DAPI. Lower panels demonstrate the absence of clathrin and
VE-cadherin co-localization in the cytoplasm of endothelial cells.
Images were captured using high-resolution confocal microscope with
equal gain and offset settings. Bar 20 lm. c and d Quantification of
co-localization of VE-cadherin with clathrin. Co-localization was
acquired by immunofluorescence confocal analysis of representative
images of four independent experiments in three triplicates and
quantified using the ImageJ co-localization plug-in. Values are
displayed as mean ± SEM (n = 12; *, ** P at least \0.05)
b
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formation was less pronounced compared to control
(Supplemental Fig. S3a). We suggested that ROCK-II
could be required for the stress fiber formation induced by
T-cad overexpression. This hypothesis was further chal-
lenged using Y27632—inhibitor of Rho kinase ROCK.
Y27632 induced relaxation of stress fibers in T-cad HU-
VEC (compare Supplemental Fig. S3a and Supplemental
Fig. S3b), suggesting that ROCK-II acts downstream of
RhoA and mediates T-cad effects on the actin cytoskeleton.
Also our data on the increased content of ROCK-II in
the nuclei of T-cad cells (Supplemental Fig. S3a) indicate
to the potential involvement of ROCK-II activation and
nuclear signaling in these cells, although more studies are
needed to establish its nuclear-specific function.
We also addressed the question if the observed effects of
T-cad on Rho GTPase activation and cytoskeletal reorga-
nization were specific. For that we analyzed the phos-
phorylation level of Src, p38, and ERK1/2. Western
blotting revealed that overexpression of T-cad as well as
downregulation of T-cad had no significant effect on Src,
p38, and ERK1/2 activation, since there was no pro-
nounced change in the contents of p-Src, p-p38, and
p-ERK1/2 at the constant total level of these proteins
(Supplemental Fig. S4). The presented data indicate that
T-cad overexpression in HUVEC reduces endothelial bar-
rier function suggesting the involvement of VE-cadherin
Fig. 5 VE-cadherin becomes phosphorylated on Tyr731 but not on
Tyr658 upon T-cad overexpression. The amount of phospho-VE-
cadherin (p-VE-cadherin) was analyzed in T-cad, si-T-cad, and
control cells using Western blotting. Phosphorylation of VE-cadherin
was evaluated in total lysates using antibodies against p-VE-cadherin
on Y731 and Y658. Western blotting data of phospho-VE-cadherin
content in cell lysates was evaluated by total VE-cadherin and
GAPDH level. Representative blots of three independent experiments
are shown
Fig. 6 Overexpression of T-cad in endothelial cells had no effects on
b-catenin, while T-cad silencing resulted in the increase of p120ctn
content in the cell membrane. Representative blots of three indepen-
dent experiments are shown and densitometry analysis histograms are
given (n = 3; P [ 0.05). a Expression of b-catenin after subcellular
fractionation was analyzed by Western blotting and densitometry
analysis in (d), (e), and (f). b b-catenin phosphorylation level were
determined in total lysates of control, T-cad, and si-T-cad cells using
antibodies against p-b-catenin on T41 (p-beta-ctn T41) using Western
blotting and densitometry analysis in g. T-cad expression exerts no
effect on b-catenin localization in cellular compartments or b-catenin
phosphorylation. Data was normalized by total b-catenin (beta-ctn)
content. c The content of p120ctn in subcellular fractions was analyzed
by Western blotting and densitometry analysis in (h), (i), and (j).
Suppression of T-cad resulted in the increase of p120ctn in the
membrane fraction compared to control and T-cad. The level of
p120ctn in cytosolic and nuclear fractions in T-cad cells was similar to
control
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clathrin-dependent endocytosis and degradation in lyso-
somes, activation of Rho GTPases and their downstream
proteins followed by enhanced actin stress fiber
polymerization.
Discussion
The accumulated evidence indicated that there is a corre-
lation between upregulated T-cad expression in vascular
cells and the progression of cardiovascular disease such as
atherosclerotic lesions and restenosis [11, 12, 28]. In
addition, the elevated expression of T-cad was suggested to
be involved in the pathogenesis of insulin resistance in
endothelial cells through the mechanism of chronic acti-
vation of the Akt/mTOR-dependent negative feedback loop
and the increased degradation of insulin receptor substrate
[29]. These data suggest that T-cad upregulation may
precede or reflect the activation/dysfunction of endothelial
cells, enhanced permeability of endothelium and vascular
injury in the above-mentioned pathological conditions.
We describe here a new mechanism of regulation of
endothelial permeability involving T-cad. The elevated
expression of T-cad impairs the endothelial barrier function
via the activation of Rho GTPases signaling, VE-cadherin
phosphorylation with subsequent clathrin-dependent
endocytosis and degradation in lysosomes, and reorgani-
zation of the actin cytoskeleton. Suppression of T-cad
causes the opposite effect. These data are in accordance
with the previously published results. Complex signaling
network that involves T-cad in the regulation of endothelial
barrier was suggested by Andreeva and co-authors. They
showed that T-cad is involved in the reduction of the
transendothelial resistance upon stimulation with thrombin
or serum; however, the detailed mechanisms remained
unknown [30]. Earlier data obtained in our lab also indi-
cated that the suppression of T-cad resulted in the
decreased permeability of the endothelial monolayer to
macromolecules in vitro [7]. Previously, using a semi-
quantitative evaluation of the fluorescence upon staining
with antibodies to VE-cadherin we revealed a tendency for
increase in VE-cadherin content in the zone of adhesive
contacts in si-T-cad cells [7]. In the present paper we used
both, HUVEC overexpressing T-cad and HUVEC with
suppressed T-cad expression and applied a combination of
methods including cell fractionation, Western blotting with
densitometric analysis and confocal microscopy to reveal
the details of the mechanisms of T-cad-mediated regulation
of endothelial permeability.
Our results on the presence of T-cad in the nuclear
fraction correlate with confocal microscopy and nuclear
fractionation data previously published by Andreeva and
co-authors [30], who showed that T-cad is normally
detected in the nucleus of endothelial cells and HEK 293.
Primary structure analysis of T-cad revealed that it is
enriched in basic residues and is predicted to have nuclear
localization [30]. These points to the fact that T-cad
localization in the nuclear fraction is not an off-target
effect of cell transduction; however, the physiological
significance of this phenomenon is unclear. The T-cad
location in the nucleus supports the notion that T-cad could
be involved in the modulation of gene transcription as it
has been shown before for E-cadherin [31] and urokinase
receptor uPAR- another GPI-anchored protein [32]. The
data on upregulation of cyclin D1 in endothelial cells [33]
and activation of serum-response elements in NIH3T3
fibroblasts upon T-cad overexpression [7] are in favor of
the assumption that T-cad is transported into the nucleus to
regulate gene expression.
In case of vascular damage under pathological condi-
tions, such as atherosclerosis, hypertension, and diabetes
mellitus, the endothelial layer could be seriously impaired,
endothelial cells retracted and endothelial barrier function
compromised followed by the obvious disruption of blood
Fig. 7 T-cad activates small G proteins and their downstream
signaling adaptors ROCK-II and PAK1 in HUVEC. a Active forms
of Rho GTPases were isolated from the whole lysates of T-cad, si-T-
cad, or control cells by precipitation with Sepharose. T-cad overex-
pression resulted in the robust activation of RhoA, Rac1, and Cdc42
compared to control or si-T-cad cells. The total protein content of
RhoA, Rac1, and Cdc42 remained unchanged. The level of activation
of Rho GTPases downstream targets was evaluated by the content of
active ROCK-II (b) and PAK1 (c) in total lysates of T-cad, si-T-cad,
or control cells. T-cad overexpression resulted in the increase of
ROCK-II content and the amount of PAK phosphorylated on
threonine 212 (T212) as compared to control cells. In si-T-cad the
content of ROCK-II and the level of PAK1phosphorylation were
reduced compared to control cells
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vessels. However, many agents such as histamine, throm-
bin, cytokines, antioxidants, VEGF, and activated neutro-
phils reversibly increase endothelial permeability [5].
Thus, it has been demonstrated that VEGF interaction
with VEGFR2, results in the activation of small GTPase
Rac through Src-dependent pathway. Rac activity causes
the direct activation of its downstream target p21-activated
kinase PAK, which, in turn, promotes phosphorylation of
VE-cadherin on serine S665 [34] or tyrosine Y685 [35, 36]
and acto-myosin contraction. In another paper, it was
shown that the engagement of antigen-activated lympho-
cytes induced phosphorylation of VE-cadherin on Y645,
Y731, and Y733 followed by actin reorganization, and that
this phosphorylation was also mediated by Rho GTPase
activation [21]. Here, we revealed that T-cad overexpres-
sion resulted in strong phopshorylation of VE-cadherin
precisely on Y731 (but not on Y658) (Fig. 5) followed by
increased VE-cadherin endocytosis and endothelial per-
meability. Several studies indicated that VE-cadherin is
preferentially internalized via a clathrin-dependent path-
way [14, 17, 34, 37]. It was indeed the clathrin-dependent
endocytosis of VE-cadherin that was associated with T-cad
expression as judged by co-localization of VE-cadherin
with clathrin (but not caveolin-1). This was confirmed by
inhibitory analysis with dynasore (Fig. 3). Dynasore is a
cell-permeable inhibitor of dynamin which blocks clathrin-
dependent endocytosis [15]. Further experiments showed
co-localization of VE-cadherin with lysosome marker.
Localization of VE-cadherin in the lysosomal compartment
indicates that VE-cadherin undergoes degradation in lyso-
somes and is not subjected to recycling [14, 17].
Though in the majority of papers VE-cadherin inter-
nalization was found to proceed via clathrin-dependent
pathway as the primary way of endocytosis for classical
cadherins [34, 37], there is evidence that caveolin-1 can
also contribute to the thrombin-induced decrease in the
barrier function [38]. We found no co-localization of
caveolin-1 and VE-cadherin (Supplemental Fig. S2c) in
control, T-cad, or si-T-cad cells, indicating that caveolin-1
is not involved in T-cad-mediated regulation of cell
permeability.
In endothelial cells, cytoplasmic domain of VE-cad-
herin binds b-catenin, p120ctn, a-catenin; both b-catenin
and a-catenin connect the cadherin complex directly to
cytoskeleton mediating strong intracellular adhesion [3, 5].
Previously, VE-cadherin domain containing Y731 was
predicted to interact with b-catenin, while Y658—with
p120ctn [20–22]. Phosphorylation of VE-cadherin on these
sites disrupts the binding of b-catenin and p120ctn. Con-
sequently, b-catenin and p120ctn which are released from
the cadherin complex may be phosphorylated and degra-
ded in proteosomes of the cytoplasm; otherwise, they can
be transported to the nucleus where they participate in
regulation of gene expression [39, 40]. Our previously
obtained results using a semiquantities evaluation of the
fluorescence intensities revealed the difference in the
staining against b-catenin in the nuclei and cytoplasm in
si-T-cad and control cells [7]. Using a more precise cell
fractionation and Western blotting with densitometric
analysis we detected no statistically significant difference
in b-catenin content between the nuclear, membrane, and
cytosolic fractions, though there was a tendency in b-
catenin increase in the nuclear fraction of T-cad cells
compared to control. The amount of phosphorylated b-
catenin was also similar between control and T-cad cells
(Fig. 6b); thus, supporting the assumption that the released
from VE-cadherin complex b-catenin is not subjected to
degradation in proteosomes. These data are in accordance
with published data on T-cad overexpression resulting in
activation and stabilization of b-catenin, which is not
subjected to proteosome degradation and is translocated
into the nucleus to regulate gene expression [33]. How-
ever, the physiological role of b-catenin in T-cad-mediated
effects is still unclear and needs further studies. In the
earlier papers, it was shown that p120ctn protects VE-
cadherin form degradation thus enhancing the stability of
the cadherin-cytoskeleton complex [14, 17, 41]. Interest-
ingly, while T-cad overexpression had no effect on p120ctn
expression/localization, in si-T-cad cells we detected the
increase in p120ctn content in the membrane fraction,
suggesting that in the absence of T-cad, p120ctn could
become associated with VE-cadherin and enhance endo-
thelial barrier function (Fig. 6c). These data correlates
with recently published results by Kowalczyk and co-
authors that binding of p120ctn to VE-cadherin inhibits
endocytosis of VE-cadherin [42].
Rho GTPases (RhoA, Rac1, and Cdc42) have received
much attention as key regulators of endothelial barrier
function via controlling the phosphorylation status of
cadherin–catenin complex, stress fiber formation, and
regulation of acto-myosin complex activity [25, 26]. RhoA
itself induces the formation of actin stress fibers as well as
activates Rho kinases resulting in phosphorylation of the
myosin light chain and cell contraction [25, 43]. Cdc42 and
Rac1bind to and activate PAK1, which controls contrac-
tility through its effects on LIM kinase [43, 44]. Earlier we
have demonstrated that in NIH3T3 fibroblasts T-cad
expression induced Rac1 and Cdc42 signaling, but not
RhoA [7]. However, it is well known that the exact acti-
vation pattern of Rho GTPases and the consequences of
GTPase signaling depend profoundly on cellular context
[45]. Therefore, in the present study we used HUVEC and
assessed the activation status of Rho GTPases in control,
T-cad, and si-T-cad cells. T-cad overexpression resulted in
the activation of RhoA, Rac1, and Cdc42, whereas no
activation was found in control or si-T-cad cells. Using
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Western blotting and inhibition analysis we demonstrate
that T-cad overexpression results in activation of direct
downstream targets of Rho GTPases, PAK1, and ROCK
(Fig. 7). Subsequent confocal microscopy and inhibitory
analysis confirmed that activation of RhoA, Rac1, and
Cdc42 signaling pathways resulted in activation of their
downstream adaptor proteins resulted in the actin stress
fiber assembly (Supplemental Fig. S3).
In addition to the regulation of the cytoskeleton, Rac1/
Cdc42 signaling pathway is known to be involved in the
activation of p38/MAPK and ERK1/2 that regulate the
activity of genes responsible for cell motility, apoptosis,
inflammation as well as cell proliferation and differentiation
[46, 47]. The results of our experiments indicate that the
change in T-cad expression doesn’t affect the phosphoryla-
tion of p38 or ERK1/2 in HUVEC. Previously, Src activation
was shown to induce phosphorylation of VE-cadherin on
Y658, Y685 [5, 35], and Y731 [20] resulting in uncoupling of
the VE-cadherin from catenins and cytoskeleton. However,
we detected no activation/phosphorylation of Src in HUVEC
upon expression in T-cad or si-T-cad cells (Supplemental Fig.
S4). These results suggest that in endothelial cells T-cad
mediates Rho GTPase-dependent signaling effects, causing
changes in the organization of the cytoskeleton, but has no
effect on the activity of p38, Erk1/2, or Src.
Thus, the above data indicate that in HUVEC T-cad
overexpression diminishes endothelial barrier function
through VE-cadherin clathrin-dependent endocytosis and
degradation in lysosomes, activation of Rho GTPases and
enhanced actin stress fiber polymerization.
The present study offers a new insight on T-cad as a
regulator of endothelial permeability through the mechanism
summarized in Fig. 8. Pathological processes such as
inflammation, atherosclerosis, hypertension, and diabetes
mellitus cause a dissociation and rearrangement of endo-
thelial cells junctions and results in enhancement of endo-
thelial permeability. This study for the first time directly
demonstrates negative effects of the elevated T-cad
expression on the endothelial barrier function and positive
effects of T-cad suppression manifested as the reduction in
endothelial permeability. Our results suggest the feasible
link between elevated level of T-cad in endothelial cells of
blood vessels and progression of cardiovascular disease
characterized by the impaired barrier function.
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